Published date: 4 November 2021

This notice was replaced on 4 November 2021

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Opportunity (published 4 November 2021, last edited 5 November 2021)

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Contract summary

Industry

  • Research and development consultancy services - 73200000

Location of contract

SE1 6LH

Value of contract

£75,000

Procurement reference

CF-0453800D0O000000rwimUAA1

Published date

4 November 2021

Closing date

18 November 2021

Closing time

2pm

Contract start date

1 December 2021

Contract end date

31 March 2022

Contract type

Service contract

Procedure type

Open procedure (below threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements below the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

Yes

Description

The provision of a research study to ascertain the medication safety benefits that the introduction of Interoperable Medicines Standards will generate in practice.
To review the competition documents and submit a bid please follow this link:

https://health-family-contract-search.secure.force.com/ProSpend__CS_ContractPage?SearchType=Projects&uid=a074J00000HQZgiQAH&searchStr=&sortStr=Recently+Published&page=1&filters=&County=

More information

Links

About the buyer

Contact name

Charlie Stephens

Address

Skipton House
London
SE1 6LH
GB

Telephone

07702406206

Email

charlie.stephens@nhs.net